France is preparing to order 100 million doses of influenza A (H1N1) vaccine from GlaxoSmithKline, Novartis, sanofi-aventis and Baxter for an estimated 700 million euros ($983 million), according to a report in Le Parisien on Thursday.

[ad]

The quantity to be bought is expected to be sufficient to protect the country’s entire population, the newspaper said, citing sources close to the French prime minister’s office. Delivery of the vaccines is reportedly scheduled to begin on September 15. France has confirmed 403 cases of H1N1 infection since the influenza outbreak began in April.

Source: FirstWord

Popularity: 3% [?]